{"id":12880,"date":"2009-12-02T11:30:00","date_gmt":"2009-12-02T10:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/dompe-e-prevedibile-una-ulteriore-riduzione-degli-informatori-tecnico-scientifici\/"},"modified":"2009-12-02T11:30:00","modified_gmt":"2009-12-02T10:30:00","slug":"dompe-e-prevedibile-una-ulteriore-riduzione-degli-informatori-tecnico-scientifici","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/dompe-e-prevedibile-una-ulteriore-riduzione-degli-informatori-tecnico-scientifici\/","title":{"rendered":"Domp\u00e8: a further reduction in Technical-Scientific Representatives is foreseeable."},"content":{"rendered":"<p><img decoding=\"async\" style=\"width: 100px\" id=\"DLImmagini__ctl56_Img\" border=\"0\" alt=\"\" src=\"http:\/\/www.informatori.aiisf.it\/img\/Archivio\/\/N2922.jpg\" width=\"100\" \/>&nbsp;<\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\" face=\"Calibri\">The Italian Pharmaceutical Industry, almost half of which is based in Lombardy, is resisting the crisis and forecasts stable turnover for 2010 as well, with a slight increase in volumes. However, the continued compression of margins due to cost containment measures is worrying.<\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\" face=\"Calibri\">If this trend continues, companies will have to cut investment in research with the risk of ending up on the margins of global business. <strong>And in the meantime, a further reduction in Technical-Scientific Representatives is foreseeable.<\/strong><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\" face=\"Calibri\">This is the state of the art outlined on 30 November in Milan by Sergio Domp\u00e8, president of Farmindustria, in the framework of a conference organized by Assolombarda.<\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><font size=\"3\" face=\"Calibri\">From &quot;Il Giorno&quot; - 1\/12\/2009 page 28<\/font><\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; L&rsquo;Industria Farmaceutica Italiana, per la quasi met&agrave; insediata in Lombardia, resiste alla crisi e prevede un fatturato stabile anche per il 2010, con un leggero aumento dei volumi. Preoccupa per&ograve; la continua compressione dei margini dovuta alle manovre di contenimento della spesa. Se questa tendenza continuer&agrave;, le imprese dovranno tagliare gli investimenti in ricerca &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12880"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12880\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}